BIM
IRWD icon

BlackRock Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7.41M Sell
578,451
-2,180
-0.4% -$27.5K 0.01% 1317
2016
Q3 		$7.72M Buy
580,631
+5,481
+1% +$64.1K 0.01% 1176
2016
Q2 		$6.3M Buy
575,150
+48,857
+9% +$477K 0.01% 1279
2016
Q1 		$4.82M Buy
526,293
+21,467
+4% +$177K 0.01% 1403
2015
Q4 		$4.9M Buy
504,826
+2,588
+0.5% +$25K 0.01% 1402
2015
Q3 		$4.38M Sell
502,238
-5,539
-1% -$51.7K 0.01% 1464
2015
Q2 		$5.13M Buy
507,777
+113,469
+29% +$1.32M 0.01% 1478
2015
Q1 		$5.28M Buy
394,308
+6,725
+2% +$88.2K 0.01% 1327
2014
Q4 		$4.97M Sell
387,583
-3,870
-1% -$44.3K 0.01% 1362
2014
Q3 		$4.25M Buy
391,453
+2,279
+0.6% +$26.1K 0.01% 1453
2014
Q2 		$5M Buy
389,174
+38,502
+11% +$419K 0.01% 1393
2014
Q1 		$3.62M Buy
350,672
+45,656
+15% +$513K 0.01% 1623
2013
Q4 		$2.97M Sell
305,016
-7,149
-2% -$64.2K ﹤0.01% 1731
2013
Q3 		$3.1M Buy
312,165
+19,165
+7% +$188K 0.01% 1624
2013
Q2 		$2.44M Buy
+293,000
New +$3.55M ﹤0.01% 1715

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's IRWD Position: Q4 2016 in Review

BlackRock Investment Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 0.38% in Q4 2016, selling an estimated $27.5K and leaving 578,451 shares worth $7.41M. The position accounts for 0.01% of the portfolio, ranked #1317.

BlackRock Investment Management first reported a position in IRWD in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.72M in Q3 2016. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • BlackRock Investment Management held 578,451 shares of Ironwood Pharmaceuticals worth $7.41M as of Q4 2016.
  • BlackRock Investment Management sold 2,180 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $27.5K.
  • Ironwood Pharmaceuticals made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1317 holding.
  • BlackRock Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Ironwood Pharmaceuticals position peaked at $7.72M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.